Evidence map›Paper›PMID 37416758›Full record

ArticleOpen forum infectious diseases2023

A Prospective Study of Key Correlates for Household Transmission of Severe Acute Respiratory Syndrome Coronavirus 2.

Elizabeth R Brown, Meagan P O'Brien, Brian Snow, Flonza Isa, Eduardo Forleo-Neto, Kuo-Chen Chan, Peijie Hou, Myron S Cohen, Gary Herman, Ruanne V Barnabas

Open access · goldAbstract read
In one paragraph

Article in Open forum infectious diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Elizabeth R BrownVaccine and Infectious Disease and Public Health Services Divisions, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
Meagan P O'BrienGlobal Development, Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA.
Brian SnowGlobal Development, Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA.
Flonza IsaGlobal Development, Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA.
Eduardo Forleo-NetoGlobal Development, Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA.
Kuo-Chen ChanGlobal Development, Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA.
Peijie HouGlobal Development, Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA.
Myron S CohenInstitute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Gary HermanGlobal Development, Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA.
Ruanne V BarnabasDivision of Infectious Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Regeneron (United States) · USFred Hutch Cancer Center · USMassachusetts General Hospital · USUniversity of North Carolina at Chapel Hill · US

Funding

Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG) - Momi-Vax DMID #21-0004 {Supplement #6}UM1AI148684 · NIAID · EMORY UNIVERSITY · PI DAVID S STEPHENS · 2020 to 2026
$77.2M
NIAID NIH HHS UM1 AI148684
6 · The paper itself

Abstract

Background: Randomized controlled trials evaluated monoclonal antibodies for the treatment (Study 2067) and prevention (Study 2069) of coronavirus disease 2019 (COVID-19). Household contacts of the infected index case in Study 2067 were enrolled in Study 2069 and prospectively followed; these cohorts provided a unique opportunity to evaluate correlates of transmission, specifically viral load. Methods: This post hoc analysis was designed to identify and evaluate correlates of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission, adjusting for potential confounding factors related to source SARS-CoV-2 viral load and risk of SARS-CoV-2 acquisition in this population. Correlates of transmission were evaluated in potential transmission pairs (any infected household member plus susceptible household contact). Results: In total, 943 participants were included. In multivariable regression, 2 potential correlates were determined to have a statistically significant ( Conclusions: In this prospective, post hoc analysis that controlled for confounders, the 2 key correlates for transmission of SARS-CoV-2 within a household are sharing a bedroom and increased viral load, consistent with increased exposure to the infected individual.

Indexed as

acquisitionCOVID-19householdSARS-CoV-2transmission

Identifiers

PMID37416758
PMCPMC10319621
OpenAlexW4378071886

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.